Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from DOCS

Google Docs AI Open to Prompt Injection Attacks, Exposing Users to Phishing or Misinformation

Adding a prompt in your document will cause the 'refine text' to follow it, changing the output and leaving readers open to phishing.

Tom’s Hardware

Google Docs' 'pageless' mode is no longer the default view on Android

Google Docs' 'pageless' mode is no longer the default view on Android

Google Docs will now open documents in paginated mode when you first open it on a mobile phone or tablet.

Android Central

County directors unite to demand greater say in how domestic game is run

County directors unite to demand greater say in how domestic game is run

The DOCs feel there is an “urgent need for a review of the standard player contract”.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Google Docs is getting a whole lot smarter - and collapsable?

Collapsible headings, with definable default states, are coming to Google Docs - should you want that.

Google wants you to help sculpt the future of AI - here's how you can get involved

Gmail and Google Docs are one step closer to getting full AI support, but users outside the US are left waiting.

Best Google Docs Add-ons for Teachers

Get the best Google Docs Add-ons to help make teaching easier and more effective.

Looking At Doximity's Recent Unusual Options Activity

A whale with a lot of money to spend has taken a noticeably bullish stance on Doximity. Looking at options history for Doximity (NYSE:DOCS) we detected 18 strange trades.

inkl

Read news from The Economist, FT, and more,
with one subscription

Is This Health Care Stock Still a Good Play 1 Year After Its IPO?

Is This Health Care Stock Still a Good Play 1 Year After Its IPO?

Doximity Inc. (DOC) made its stock market debut on June 25, 2021. However, the stock has lost 19.2% over the past year. So, let’s evaluate if it is worth buying the stock now….

Stock Split or Not: 3 Stock to Avoid

Stock Split or Not: 3 Stock to Avoid

Amid the stock split trend, irrespective of whether Shopify (SHOP), MercadoLibre (MELI), and Doximity (DOCS) are undergoing a stock split in the near term or not, these stocks aren’t well-positioned to survive the market slump. So, they are best avoided now. Let’s discuss….

If You’d Like To Dabble In The 80s Fashion Resurgence This Winter, We’ve Found The Perfect ’Fits

If You’d Like To Dabble In The 80s Fashion Resurgence This Winter, We’ve Found The Perfect ’Fits

Big hair not included.

Looking At Doximity's Recent Whale Trades

Looking At Doximity's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Doximity (NYSE:DOCS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

What 5 Analyst Ratings Have To Say About Doximity

What 5 Analyst Ratings Have To Say About Doximity

Within the last quarter, Doximity (NYSE:DOCS) has observed the following analyst ratings:

Why Doximity Shares Are Trading Lower After Hours

Why Doximity Shares Are Trading Lower After Hours

Doximity Inc (NYSE:DOCS) reported fourth-quarter revenue growth of 40.4% year-over-year to $93.7 million, beating the consensus of $90.11 million. Adjusted net income was $44.9 million versus $24 million in 4Q21, representing a 48% margin. Adjusted EPS was $0.21, beating the consensus of $0.15. Adjusted gross margin expanded by 200 bps to 90%.…

Is Doximity a Good Growth Stock to Own?

Is Doximity a Good Growth Stock to Own?

Shares of Doximity (DOCS), a cloud-based digital platform for medical professionals, recently reported impressive third-quarter financials, beating the consensus EPS estimate. However, is it wise to buy the stock amid the subdued climate for growth companies? Let’s find out.

Get all your
news in one place.

100's of premium titles.
One news app.

Where Doximity Stands With Analysts

Within the last quarter, Doximity (NYSE:DOCS) has observed the following analyst ratings:

Why Doximity Shares Are Trading Higher Premarket Today?

Doximity Inc (NYSE: DOCS) posted Q3 FY22 sales of $9

Can you hike in Doc Martens? We take a look

Can you hike in Doc Martens? We set gear snobbery aside and weigh function over fashion to provide the answer to this oft-asked question

1 2

People

Albert Einstein

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Google Workspace

Google Classroom

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

406,618 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play